Ovarian Cancer Drug Shows Eye and Nerve Risks in Large Real-World Study
A large real-world analysis of TriNetX health records finds that mirvetuximab soravtansine carries elevated risks of corneal toxicity and peripheral ...
Tag: platinum-resistant ovarian cancer
Turning Cold Tumors Hot: Dual-Target Therapy Offers New Hope for Platinum-Resistant Ovarian Cancer
A new review outlines how combining PARP inhibitors with immune checkpoint inhibitors can convert immunologically cold ovarian tumors into hot ...
First patient enrolled in Phase 3 trial of mocertatug rezetecan for platinum-resistant ovarian cancer
Philadelphia, PA, USA — July 27, 2026 — The GOG Foundation, Inc. announced the enrollment of the first patient in ...
Breakthrough Phase II Study in Platinum-Resistant Ovarian Cancer Set for Presentation at ESGO 2026
At the forefront of gynecologic oncology, a significant breakthrough is poised to reshape the clinical landscape for women battling platinum-resistant ...
Research Reveals That Treatment Predictions by Platform Technology Enhance Outcomes in Platinum-Resistant Ovarian Cancer
Recent advancements in cancer treatment have yielded promising results, notably in a newly published Phase 3 trial that investigates the ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!